Yang, Jinming <br/><br/>
Molecular determinants of melanoma malignancy: selecting targets for improved efficacy of chemotherapy.  [electronic resource] 

 -  Molecular cancer therapeutics  Mar 2009 
 - 636-47 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1535-7163 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-08-0749  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--therapeutic use<br/>Benzenesulfonates--administration & dosage<br/>Biomarkers, Tumor--genetics<br/>Dacarbazine--administration & dosage<br/>Drug Delivery Systems--methods<br/>Drug Synergism<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Imidazoles--administration & dosage<br/>Melanoma--drug therapy<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Models, Biological<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds<br/>Pyridines--administration & dosage<br/>Quinoxalines--administration & dosage<br/>Skin Neoplasms--drug therapy<br/>Sorafenib<br/>Substrate Specificity<br/>Temozolomide<br/>Treatment Outcome<br/>Tumor Cells, Cultured<br/>Xenograft Model Antitumor Assays